An Immunohistochemical Study of E-Cadherin Expression in Human Squamous Cell Carcinoma of the Skin
The Journal of Dermatology. 1999;26(7):416-422 
nm23?Relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients
Cancer. 1997;79(6):1158-1165
Neck Dissection for Advanced Lymph Node Metastasis Before Definitive Radiotherapy for Primary Carcinoma of the Head and Neck
The Laryngoscope. 2000;110(7):1210-1214
Evaluation of Expression Of ADAM 10 as a Predictor of Lymph Node Metastasis in Oral Squamous Cell Carcinoma—An Immunohistochemical Study
Head and Neck Pathology. 2022;
Expression pattern of adhesion molecules (E-cadherin, ?-, ?-, ?-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis
APMIS. 2007;115(1):52-65
E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma
British Journal of Cancer. 1996;74(8):1237-1241
Genetic dissimilarity between primary colorectal carcinoma and their lymph node metastases: Ploidy, p53, Bcl-2 and c-myc expression
Pathology. 2016;48:S124
“P53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: P53 mutations in primary tumor and matched lymph node metastases” by G.W.A. Tjebbes et al. Oral Oncology 35, pp 384–389.
Oral Oncology. 2000;36(4):395
Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases
Head & Neck. 2003;26(1):22-30
P53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: P53 mutations in primary tumor and matched lymph node metastases
Oral Oncology. 1999;35(4):384-389